1.Functional Importance of Left Ventricular Long Axis Movement in Mitral Valvular Heart Disease.
Eun Seok JEON ; Ki Nam PARK ; Byung Su KWAK ; Dae Hoe KU ; Back Su KIM ; Yong Seok CHOI ; Chong Hun PARK ; Seung Pyung LIM ; Young LEE
Korean Circulation Journal 1991;21(6):1174-1181
BACKGROUND: The effective ventricular function during ejection and filling is likely to depend on the coordinated action of the longitudinally and circumferentially orientated myocardial fibers and the function of these longitudinal fibers has not been extensively studied. METHODS: The role of longitudinally and circumferentially orientated fibers in left ventricular wall motion was evaluated by M-mode echocardiograms of the mitral ring(whose motion reflect long axis change) and the standard minor axis(left ventricular posterior wall), simultaneous recordings of phonocardiograms and electrocardiograms on the paper (speed 100mm/sec), in 24 healty individuals, 17 patients with mitral stenosis, 11 patients with open mitral commissurotomy and 17 mitral valve replaced patients. RESULTS: In the controls long axis shortening significantly preceded minor axis shortening (phase difference between two axes : 20+/-3 msec, mean+/-SEM) during early systole, indicating left ventricle become more spherical. This phase difference was also observed in the patients with mitral stenosis and in those with open mitral commissurotomy. In patients with mitral valve replacement(MVR) whose papillary muscles had been sectioned, the onset of long axis shortening was more delayed during early systole than that of short axis(-33+/-6msec) and the end of shortening was also prolonged to early diastole more than that of normal controls (54+/-3 msec vs 90+/-8 msec, mean+/-SEM, p<0.01 by t-test). CONCLUSION: We observed the time relations between long and short axis motion in normal controls. It can be concluded that the reversed time relation in patients with MVR is one of the important factors which may effect negatively on ventricular function and long-term prognosis, thus the surgical procedures to preserve papillary annular continuity should be considered in patients with mitral valvular disease. And the controlled, prospective, clinical trials with homogenous groups of patients are needed to evaluate the potential benefits of papillary annular continuity in preserving atrio-ventricular interaction in patients undergoing mitral valvular surgery.
Axis, Cervical Vertebra*
;
Diastole
;
Echocardiography
;
Electrocardiography
;
Heart Valve Diseases*
;
Heart Ventricles
;
Humans
;
Mitral Valve
;
Mitral Valve Stenosis
;
Papillary Muscles
;
Prognosis
;
Systole
;
Ventricular Function
2.Comparison of Cost Efficacy of Ectopic Pregnancy Management.
Dae Young CHUNG ; Jong Chul SHIN ; Eun Jung BAIK ; Young LEE ; Young Oak LEW ; Jong Kun LEE ; Chang Yi KIM ; Dae Hoon KIM ; Su Pyung KIM
Korean Journal of Obstetrics and Gynecology 1998;41(12):2942-2946
The incidence of ectpic pregnancy has increased rapidly over the past decade. Currently, the complications of this disorder make it one of the leading causes of maternal mortality and morbidity. In the late 1980s, reports of successful use of methotrexate (MTX) as a non surgical treatment for ectopic pregnancy (EP) also began to appear in the literature. With MTX emerging as a possible alternative management of selected women with an EP, an analysis of its comparative costs is now needed. We examined retrospectively the costs associated with management of EP in our hospital. We selected 30 women with EPand divided them into two groups of MTX treated group (n= l0) and surgically treated group (n=20). There were no statistically significant differences in the doctors fee, room, charge and cost of laboratory and radiologic examination between two groups. But We found significant reduction in cost with regard to pharmacy, injection, procedure and operation of MTX treated group compared to surgically treated group (p<0.05). Consequently the use of MTX for EP should still be considered investigational; we recognize and agree that the evolution of this remedial option should be based primarily on its ability to decrease morbidity and mortality rather than on its ability to reduce costs. If medical treatment proves to be effective, the potential cost savings demonstrated in this report will become an important influential factor on selecting alternative remedy.
Cost Savings
;
Fees and Charges
;
Female
;
Humans
;
Incidence
;
Maternal Mortality
;
Methotrexate
;
Mortality
;
Pharmacy
;
Pregnancy
;
Pregnancy, Ectopic*
;
Retrospective Studies
3.A Case of Uterine Rupture in the 18th Week of Pregnancy.
Su Chin YANG ; Eun Na CHO ; So Yang PARK ; Mi Hee KIM ; Pyung Jum KIM
Korean Journal of Obstetrics and Gynecology 2002;45(2):315-317
Spontaneous uterine rupture during the second trimester of pregnancy is a rare obstetric emergency. When a patient presents with acute abdominal pain and signs of hemorrhagic shock, a number of differential diagnoses must be considered. Early diagnosis and proper management is necessary to decreased the high maternal and fetal morbidity and mortality associated with rupture of uterus. We present a case of spontaneous rupture of the uterus in the 18th week of pregnancy with a brief review of literatures.
Abdominal Pain
;
Diagnosis, Differential
;
Early Diagnosis
;
Emergencies
;
Female
;
Humans
;
Mortality
;
Pregnancy Trimester, Second
;
Pregnancy*
;
Rupture
;
Rupture, Spontaneous
;
Shock, Hemorrhagic
;
Uterine Rupture*
;
Uterus
4.Comparison of Distribution of Fibronectin and Fibrinogen in Placenta between Normotensive and Preeclamptic Pregnancies.
Dae Young CHUNG ; Jong Kun LEE ; Jong Chul SHIN ; Chong Seong YI ; Young LEE ; Eun Jung BAIK ; Chang Yi KIM ; Su Pyung KIM ; Woon Sub HAN
Korean Journal of Obstetrics and Gynecology 1998;41(12):2947-2951
In order to find out the distribution of fibronectin and fibrinogen in placenta among pregnancy induced hypertensive (PIH) patients, 6 normotensive pregnancies and 17 PIH patients were chosen. The placentas were obtained right after delivery and soaked in the 10% formalin solution. The score was measured in terms of the positiveness of the stain in immunohistochemical stain by using I antibody with the rabbit antihuman fibronectin and the rabbit anti-human fibrinogen. Comparison between two groups are as following: 1.The placenta of PIH patients showed significantly reduced positiveness of fibronectin in their fetal villous vessels and villous stroma. 2. In the PIH patients, the positiveness was reduced in the group giving the birth to intrauterine fetal growth retardation compared to giving birth to normal baby. 3. In both normotensive and PIH patients, the villous basement membrane did not show the staining response to fibronectin, while showing heavy staining response to fibrinogen. 4. The positiveness of fibrinogen in fetal vessels, villous basement membrane, intervillous space and stroma were almost same in both normotensive and PIH patients. From above results, we can conclude that there is abnormality in the distribution of fibronectin especially in the fetal vessels and the villous stroma of placenta among PIH patients. The cause of this result needs further study.
Basement Membrane
;
Fetal Growth Retardation
;
Fibrinogen*
;
Fibronectins*
;
Formaldehyde
;
Humans
;
Parturition
;
Placenta*
;
Pre-Eclampsia
;
Pregnancy*
5.A case of primary peritoneal leiomyoma.
Mi Lan SANG ; Tae Chul PARK ; Yong Il KWON ; Chan Joo KIM ; Dong Jin KWON ; Jin Woo LEE ; Su Pyung KIM
Korean Journal of Obstetrics and Gynecology 1999;42(11):2592-2595
Primary peritoneal leiomyoma is histologically benign and rare non-neoplastic proliferation of smooth muscle that occurs in the peritoneal wall during the reprodutive years of women. A 51-year old patient had a solid tumor of 18cm diameter in the peritoneal wall, which was pathologically confirmed as a benign leiomyoma primarily originated from the retroperitoneal wall. Laparotomy revealed a solid tumor in the peritoneal wall, about 18cm, and histologically diagnosed as a leiomyoma. We report a case of primary peritoneal leiomyoma with a brief review of literatures.
Female
;
Humans
;
Laparotomy
;
Leiomyoma*
;
Middle Aged
;
Muscle, Smooth
6.Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature.
Su Kyung PARK ; Pyung Han HWANG ; Seok Kweon YUN ; Han Uk KIM ; Jin PARK
Annals of Dermatology 2017;29(1):74-78
The development of cutaneous sarcoidosis as a paradoxical adverse event of tumor necrosis factor alpha (TNF-α) blockers has been reported in the literature; however, an erythrodermic form of cutaneous sarcoidosis during anti-TNF-α therapy has not yet been reported. Herein, we report the first case of an erythrodermic form of cutaneous sarcoidosis during anti-TNF-α therapy and review previous studies of cutaneous sarcoidosis. A 6-year-old Korean girl who had been suffering from juvenile rheumatoid arthritis presented with generalized erythematous skin eruption involving more than about 90% of her body surface area. After 14 months of etanercept treatment, the new erythematous skin eruption had developed and progressed into generalized erythroderma. Exclusion of suspected co-medication had been performed based on medication history. She had no other systemic symptoms, and ophthalmologic and neurologic examinations were normal. Histopathologic findings of the skin lesion revealed diffuse non-caseating granulomatous infiltrates composed of epithelioid histiocytes with sparse lymphocytes involving the entire dermis. Periodic-acid-Schiff and acid-fast stains were negative, and acid-fast bacilli was not detected by polymerase chain reaction of the skin biopsy. Based on clinicopathologic findings, she was diagnosed with etanercept-induced sarcoidal granuloma. After discontinuation of the suspected agent, the lesions spontaneously disappeared.
Arthritis, Juvenile*
;
Biopsy
;
Body Surface Area
;
Child
;
Coloring Agents
;
Dermatitis, Exfoliative
;
Dermis
;
Etanercept
;
Female
;
Granuloma
;
Histiocytes
;
Humans
;
Lymphocytes
;
Neurologic Examination
;
Polymerase Chain Reaction
;
Sarcoidosis*
;
Skin
;
Tumor Necrosis Factor-alpha*
7.Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature.
Su Kyung PARK ; Pyung Han HWANG ; Seok Kweon YUN ; Han Uk KIM ; Jin PARK
Annals of Dermatology 2017;29(1):74-78
The development of cutaneous sarcoidosis as a paradoxical adverse event of tumor necrosis factor alpha (TNF-α) blockers has been reported in the literature; however, an erythrodermic form of cutaneous sarcoidosis during anti-TNF-α therapy has not yet been reported. Herein, we report the first case of an erythrodermic form of cutaneous sarcoidosis during anti-TNF-α therapy and review previous studies of cutaneous sarcoidosis. A 6-year-old Korean girl who had been suffering from juvenile rheumatoid arthritis presented with generalized erythematous skin eruption involving more than about 90% of her body surface area. After 14 months of etanercept treatment, the new erythematous skin eruption had developed and progressed into generalized erythroderma. Exclusion of suspected co-medication had been performed based on medication history. She had no other systemic symptoms, and ophthalmologic and neurologic examinations were normal. Histopathologic findings of the skin lesion revealed diffuse non-caseating granulomatous infiltrates composed of epithelioid histiocytes with sparse lymphocytes involving the entire dermis. Periodic-acid-Schiff and acid-fast stains were negative, and acid-fast bacilli was not detected by polymerase chain reaction of the skin biopsy. Based on clinicopathologic findings, she was diagnosed with etanercept-induced sarcoidal granuloma. After discontinuation of the suspected agent, the lesions spontaneously disappeared.
Arthritis, Juvenile*
;
Biopsy
;
Body Surface Area
;
Child
;
Coloring Agents
;
Dermatitis, Exfoliative
;
Dermis
;
Etanercept
;
Female
;
Granuloma
;
Histiocytes
;
Humans
;
Lymphocytes
;
Neurologic Examination
;
Polymerase Chain Reaction
;
Sarcoidosis*
;
Skin
;
Tumor Necrosis Factor-alpha*
8.Randomized comparison of the effects of the endocervical and the vaginal prostaglandinE2 in women with various degrees of cervical ripeness.
Mi Ran SANG ; Yong Il KWON ; Tae Chul PARK ; Dong Jin KWON ; Yong Suk LEE ; Tae Wook BAE ; Jin Woo LEE ; Su Pyung KIM
Korean Journal of Obstetrics and Gynecology 1999;42(10):2176-2181
OBJECTIVES: The trial was performed to obtain an unbiased comparison of the relative merits of endocervical and vaginal prostaglandin E2(PGE2) in the case of parous and nulliparous woman with favorable and unfavorable cervical features. This study was performed to determine the clinical usefullness of endocervical PGE2 comparing with the vaginal PGE2 in cervical ripening and induction of labor. METHOD: The randomized trial with 65 Participants was performed with sealed envelopes for parity and Bishop score (from March to september, 1998). PGE2 tablet(3mg Dinoprostone) was administrated intravaginally to the 32 pregnant women and endocervically to the 33 pregnant women every eight hours with maximum three times until the regular labor develped. RESULT: Outcomes of labor and delivery were clearly related to cervical score at trial entry. endocerval PGE2 had a more marked effect on cervical ripeness than did vaginal PGE2. There were no significant differences on age distribution, gestatioanal period, primiparity, cervical status, initial B-score in each group. There were no significant differences in cesarian section rate, fetal distress, uterine hyperstimulation, side effect and poor infant outcome between the groups The mean induction time was statistically shorter in cervical group with multiparous women than other group(p=0.0195). In the induction-active labor time, cervical with primi group was statistically shorter than other group(p=0.0245). Statistically significant differences were noted between the nulliparous woman and multiparous women in mean induction time, induction-active labor time, time to B-score 8. In the factor that effects induction-active labor, route was significantly better than other factor.(p=0.0001) CONCLUSION: edocervical PGE2 is more effctive than vaginal PGE2 in cervical ripening and induction of active labor. the endocervical PGE2 resulted in a significantly shorter induction to active labor time compared with vaginal PGE2 and has almost no side effect. Because differences in effectiveness between endocervical and vaginal PGE2 are marginal, preference of woman and clinicians can the choice between them.
Age Distribution
;
Cervical Ripening
;
Dinoprostone
;
Female
;
Fetal Distress
;
Humans
;
Infant
;
Parity
;
Pregnancy
;
Pregnant Women
9.Four cases report of congenital factor VII deficiency.
Yoo Jeong DOH ; Mi Hyang KIM ; Chung Hyun NAHM ; Kyung Soon SONG ; Oh Hun KWON ; Eung Chang CHOI ; Chae Yoon CHON ; Pyung Moon PARK ; Su Bong HAN
Korean Journal of Hematology 1992;27(2):435-441
No abstract available.
Factor VII Deficiency*
;
Factor VII*
10.Cord Blood Erythropoietin Complicated By High Risk Pregnancies.
Seock Won KIM ; Sa Jin KIM ; Gui Se Ra LEE ; In KWUN ; Jae Dong LEE ; Hyung Gun LEE ; Jung Hui PARK ; Gi Hong JIN ; Jong Chul SHIN ; Su Pyung KIM
Korean Journal of Obstetrics and Gynecology 2000;43(6):1062-1065
OBJECTIVE: To investigate the relationship between umbilical plasma erythropoietin(epo) concentrations and umbilical cord pH in high risk pregnancies. METHODS: We measured epo concentrations and gas in 103 cases of cord blood obtained from 88 cesarean section (15 of twin) composed of 39 cases of normal control (12 of normal twins), 45 cases of high risk pregnancies and 4 cases of unclassified group using an RIA kit from december,1998 to December, 1999. Statistical analysis was performed using the student's t test and regression analysis. P values less than 0.05 were considered statistically significant. RESULTS: Umbilcal plasma epo concentrations revealed significant inverse correlation (P<0.05) with umbilical acidosis and cord blood epo levels, and it were significantly higher in GDM and IUGR than normal pregnancies (control: 1.60 1.15, n=39 versus GDM: 7.78 7.18, n=11 versus IUGR: 64.77 90.57 n=10, p<0.05), but 11 cases of fetal distress and 13 cases of preeclampsia did not differ significantly from umbilical plasma epo of normal control. CONCLUSIONS: Elevated epo concentrations in cord blood indicate fetal hypoxia and It is significantly increased in IUGR and GDM, these findings show that cord blood epo may serve as a clinically useful marker for chronic fetal hypoxia.
Acidosis
;
Cesarean Section
;
Erythropoietin*
;
Female
;
Fetal Blood*
;
Fetal Distress
;
Fetal Growth Retardation
;
Fetal Hypoxia
;
Hydrogen-Ion Concentration
;
Plasma
;
Pre-Eclampsia
;
Pregnancy*
;
Umbilical Cord